http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0681480-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e768f92cdf7ce861a72a0c4147d92ea |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4731 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 1994-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da57791b18a2435f427d0f2528268c97 |
| publicationDate | 1995-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0681480-A1 |
| titleOfInvention | Recognin vaccines |
| abstract | The invention is directed to a vaccine containing the tumor markers, Regognin L, Recognin M or malignin, for the prevention of treatment of cancer. Anti-Recognin antibodies inhibit the growth of small lung carcinoma cells in vitro. Anti-recognin antibody levels increase with age in humans and are increased in patients with breast cancer. The invention also includes the administration of an anti-Recognin antibody for the treatment of cancer and a diagnostic assay for detecting anti-Recognin antibodies. |
| priorityDate | 1993-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.